SCGB2A2 and breast cancer: We evaluated a previously identified panel of six gene transcripts related to the presence of CTCs in patients in a larger cohort of early and metastatic breast cancer in order to investigate its clinical importance, and as in our previous study, we included EpCAM and SCGB2A2 as common markers for epithelial and breast cancer cells.